Inflammation

1.    Fischer M et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006;116:2748-56.
2.    Ferroni P et al. Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis. Curr Med Chem 2007;14:2170-80.
3.    Marnell L et al. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-11.
4.    Barthel SR et al. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 2007;11:1473-91.
5.    Yan MX et al. Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: Correlation with T lymphocyte subsets, NK cells and liver inflammation. Hepatol Res 2006;35:111-117.
6.    Yngen M et al. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 2004;47:537-40.
7.    Humbría A et al. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum 1994;37:342-8.
8.    Marshall JC. The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation. Shock 2005;24 Suppl 1:120-9.
9.    Su YC et al. Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation. J Immunol 2008;180:2600-7.
10.    Grzelewska-Rzymowska I et al. Role of intra cellular adhesion molecule-1 (ICAM-1) and its soluble form (sICAM) in chronic airway inflammation] Pol Merkur Lekarski 2004;16:179-82.
11.    Kaser A et al. Interferon-alpha in inflammation and immunity. Cell Mol Biol (Noisy-le-grand) 2001;47:609-17.
12.    Enzler T et al. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med 2003;197:1213-9.
13.    Hideki C et al. The Significance of Interferon- –Triggered Internalization of Tight-Junction Proteins in Inflammatory Bowel Disease. Sci STKE 2006;2006:pe1.
14.    Murphy JE et al. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 2000;114:602-8.
15.    Nakajima H et al. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 2007;142:265-73.
16.    Ponomarev ED et al. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007;27:10714-21.
17.    Li MO et al. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008;28:468-76.
18.    Gabay C et al. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006;8 Suppl 2:S3.
19.    Silvestri M et al. High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation? Clin Exp Allergy 2006;36:1373-81.
20.    Cho SJ et al. Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem 2006;281:8161-8.
21.    Wong CK et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000;9:589-93.
22.    McInnes IB et al. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42.
23.    Singh L et al. Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis. Pancreatology 2007;7:479-90.
24.    Chakrabarti S et al. CD40-40L signaling in vascular inflammation. J Biol Chem 2007;282:18307-17.
25.    Miller MD et al. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
26.    Ajuebor MN et al. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun 1999;255:279-82.
27.    Asano T et al. Increased macrophage inflammatory protein-1alpha and -1beta in BAL fluid of bronchiolitis obliterans organizing pneumonia. Respirology 2003;8:461-6.
28.    Woodfin A et al. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007;27:2514-23.
29.    Conti P et al. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 2001;22:133-7.
30.    Opal SM et al. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
31.    Schmidt-Weber CB et al. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004;16:709-16.
32.    Fernandez L et al. Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol 2008;36:545-558.
33.    Romero R et al. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Am J Obstet Gynecol 2000;183:1070-7.
34.    Gee K et al. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009;8:40-52.
35.    Kramer JM et al. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007;78:1083-93.
36.    McKenzie BS et al. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006;27:17-23.
37.    Hendriks JJ et al. Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 2008;204:52-7.
38.    Gadient RA et al. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 1999;17:127-37.
39.    Tsou CL et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007;117:902-9.
40.    Lalor PF et al. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 2002;80:52-64.
41.    Gao Y et al. P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin. Mol Cells 2005;19:350-5.
42.    Wu T et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 2007;179:7166-75.
43.    Witkowska AM. Soluble ICAM-1: a marker of vascular inflammation and lifestyle. Cytokine 2005;31:127-34.